- Home
- REPL vs LEGH Comparison
REPL vs LEGH Comparison
Compare REPL & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- LEGH
- Stock Information
- Founded
- REPL 2015
- LEGH 2005
- Country
- REPL United States
- LEGH United States
- Employees
- REPL N/A
- LEGH N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- LEGH Homebuilding
- Sector
- REPL Health Care
- LEGH Consumer Discretionary
- Exchange
- REPL Nasdaq
- LEGH Nasdaq
- Market Cap
- REPL 578.4M
- LEGH 588.8M
- IPO Year
- REPL 2018
- LEGH 2018
- Fundamental
- Price
- REPL $8.98
- LEGH $22.29
- Analyst Decision
- REPL Strong Buy
- LEGH Buy
- Analyst Count
- REPL 6
- LEGH 2
- Target Price
- REPL $20.00
- LEGH $29.00
- AVG Volume (30 Days)
- REPL 1.6M
- LEGH 76.7K
- Earning Date
- REPL 05-22-2025
- LEGH 05-12-2025
- Dividend Yield
- REPL N/A
- LEGH N/A
- EPS Growth
- REPL N/A
- LEGH 8.04
- EPS
- REPL N/A
- LEGH 2.29
- Revenue
- REPL N/A
- LEGH $176,618,000.00
- Revenue This Year
- REPL N/A
- LEGH N/A
- Revenue Next Year
- REPL N/A
- LEGH $9.14
- P/E Ratio
- REPL N/A
- LEGH $9.73
- Revenue Growth
- REPL N/A
- LEGH N/A
- 52 Week Low
- REPL $4.93
- LEGH $21.67
- 52 Week High
- REPL $17.00
- LEGH $29.31
- Technical
- Relative Strength Index (RSI)
- REPL 53.81
- LEGH 35.49
- Support Level
- REPL $8.25
- LEGH $21.93
- Resistance Level
- REPL $9.53
- LEGH $23.40
- Average True Range (ATR)
- REPL 0.88
- LEGH 0.92
- MACD
- REPL 0.17
- LEGH -0.15
- Stochastic Oscillator
- REPL 71.10
- LEGH 9.39
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.